Cigna Group $CI Position Boosted by Vanguard Group Inc.

Key Points

• Vanguard Group boosted its stake in Cigna by 1.6% in Q4 to 26,173,577 shares, now owning 9.80% of the company (about $7.20 billion); overall institutional and hedge fund ownership stands at 86.99%.
• Cigna beat expectations in the most recent quarter with $8.08 EPS versus a $7.88 estimate and $72.5 billion in revenue versus $69.53 billion, and it set FY2026 guidance at $30.25 EPS (analysts expect about $30.32).
• The company declared a quarterly dividend of $1.56 ($6.24 annualized, a 2.3% yield; ex-dividend June 4), while insiders reduced holdings (e.g., Nicole S. Jones sold 2,307 shares and Everett Neville sold 1,719), leaving insiders with 0.60% ownership.

Vanguard Group Inc. boosted its holdings in Cigna Group (NYSE:CI - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,173,577 shares of the health services provider's stock after buying an additional 414,834 shares during the quarter. Vanguard Group Inc. owned 9.80% of Cigna Group worth $7,203,754,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Cigna Group by 11.7% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider's stock worth $13,039,000 after buying an additional 4,738 shares during the period. Maj Invest Holding A S raised its holdings in shares of Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider's stock valued at $121,854,000 after acquiring an additional 10,042 shares during the period. Providence Capital Advisors LLC raised its holdings in shares of Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider's stock valued at $2,453,000 after acquiring an additional 7,748 shares during the period. National Pension Service lifted its holdings in shares of Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider's stock valued at $197,091,000 after purchasing an additional 21,203 shares in the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. lifted its stake in Cigna Group by 13.5% in the 3rd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider's stock worth $9,839,000 after acquiring an additional 4,066 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by company insiders.

Cigna Group Price Performance

Shares of NYSE:CI opened at $275.44 on Monday. The company has a market cap of $72.59 billion, a price-to-earnings ratio of 12.42, a PEG ratio of 0.95 and a beta of 0.26. The business has a 50 day moving average price of $274.50 and a 200 day moving average price of $277.02. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The company's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts predict that Cigna Group will post 30.32 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a $1.56 dividend. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group's dividend payout ratio (DPR) is currently 28.13%.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna joined other major plans in a public commitment to standardize electronic prior-authorization requirements for commonly reviewed services — a move that should reduce provider administrative burden, speed patient access to care, and lower long‑term costs for payers. Article Title
• Positive Sentiment: Industry press highlights progress across UnitedHealthcare, Aetna and Cigna toward standardizing prior authorization — reinforcing that this is an industry-wide trend (reduces regulatory/operational risk if successfully implemented). Article Title
• Positive Sentiment: Cigna declared a quarterly dividend ($1.56 per share; ex-dividend in June), underscoring cash return to shareholders and supporting income-focused investor demand. Dividend Announcement
• Positive Sentiment: Analysts and previews (Zacks) expect earnings growth into the next report, which could support a post‑earnings rebound if Cigna posts another beat. Article Title
• Neutral Sentiment: Cigna promoted Melissa Skottegaard to chief marketing & communications officer — a leadership move that may affect branding/execution but is unlikely to move near‑term financials. Article Title
• Neutral Sentiment: Reminders that Cigna is scheduled to report results next week (earnings date/coverage notices) keep focus on near-term catalysts rather than fundamental surprises. Article Title
• Negative Sentiment: Jefferies reaffirmed a Buy on CI but trimmed its price target slightly (reportedly from $333 to $330) after reviewing health insurance exchange exposure — the analyst tweak likely pressured sentiment and fed selling pressure. Article Title

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Jefferies Financial Group reduced their price target on shares of Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a research report on Monday, April 20th. Robert W. Baird dropped their price objective on shares of Cigna Group from $315.00 to $306.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 15th. Guggenheim reiterated a "buy" rating and issued a $318.00 target price on shares of Cigna Group in a research report on Monday, February 2nd. Leerink Partners lifted their price objective on Cigna Group from $270.00 to $297.00 and gave the company a "market perform" rating in a research report on Friday, February 6th. Finally, Royal Bank Of Canada decreased their target price on shares of Cigna Group from $344.00 to $333.00 and set an "outperform" rating for the company in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $332.47.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.